Publikācijas » 2014 » Drukāšanas versija (formatēta)

Konferences
1Vorona M.; Veinberg G.; Kazoka H.; Sproge A. Supercritical fluid chromatography separation of 5-methylsubstituted phenylpiracetam stereoisomers on polysaccharide-based chiral stationary phases (www.nosss.se/abstract). Presented at Nordic Separation Science Society (NoSSS) 7th Symposium –Advance in separation science; : Djuronaset, Sweden, 10.6., 2014.      

2Parkova A.; Vendina I.; Maurops G.; Mutule I.; Berzina L.; Romanchikova N.; Žalubovskis R.; Marescu A.; Supuran C.T.; Trapencieris P. New heterocyclic coumarin analogues as CA inhibitors.. In Program and Abstracts, International Conference on Organic Synthesis, Balticum Organicum Syntheticum, International Conference on Organic Synthesis, Balticum Organicum Syntheticum; Vilnius, Lithuania: Vilnius, Lithuania, 2014; 115.      

3Žalubovskis R.; Grandane A.; Cauņa I.; Pustenko A. Bioisosteres of coumarin as inhibitors of carbonic anhydrases.. In Program and Abstracts, International Conference on Organic Synthesis, Balticum Organicum Syntheticum, International Conference on Organic Synthesis, Balticum Organicum Syntheticum; Vilnius, Lithuania: Vilnius, Lithuania, 2014; 151.      

4Grandane A.; Žalubovskis R. Sulfocoumarins as selective inhibitors of cancer associated carbonic anhydrases. . Abstract Book, 1st EFMC young medicinal chemist symposium, EFMC-YMCS, Poster presentations/P25, 1st EFMC young medicinal chemist symposium, EFMC-YMCS; Lisbon, Portugal: Lisbon, Portugal, 2014; 70.      

5Ivanova J.; Žalubovskis R. Synthesis of unsymmetrically substituted disulfamoylbenzoic acid derivatives. . In Program and Abstracts, International Conference on Organic Synthesis Balticum Organicum Syntheticum (BOS-2014). , International Conference on Organic Synthesis Balticum Organicum Syntheticum (BOS-2014); Vilnius, Lithuania: Vilnius, Lithuania, 2014; 69.      

6Segal I.; Zablotskaya A.; Maiorov M.; Zablotsky D.; Blums E.; Abele E.; Shestakova I. Magnetite/oleic acid nanoparticles possessing immobilized antitumour tetrahydroisoquinoline derivatives. Proceedings of the 9th International PAMIR Conference on Fundamental and Applied MHD, Thermo Acoustic and Space Technologies, 9th International PAMIR Conference on Fundamental and Applied MHD, Thermo Acoustic and Space Technologies, volume 2.; Riga, Latvia, 2014; 278.      

7Segal I.; Zablotskaya A.; Maiorov M.; Zablotsky D.; Blums E.; Nikolajeva V.; Eze D. Magnetite Based Nanoparticles with Immobilized Heterocyclic Choline Derivatives as Potential Anti-Infective Agents. . Book of Abstracts of the Joint 12th Russia/CIS/Baltic/Japan Symposium on Ferroelectricity and 9th International Conference “Functional Materials and Nanotechnologies” (RCBJSF, FM&NT-2014), 12th Russia/CIS/Baltic/Japan Symposium on Ferroelectricity and 9th International Conference “Functional Materials and Nanotechnologies. F-43.; Riga, Latvia, 2014; 309.      

8Sjakste N.; Sjakste T.; Rostoka E.; Buraka E.; Baumane L.; Boucher J.-L.; Borisova V.V. IN VITRO STUDIES OF 1,4-DIHYDROPYRIDINE PEROXYNITRITE SCAVENGING AND DNA PROTECTIVE ACTIVITIES - ID: 40112. The 2nd Genetics and Genomics Conference and the 2nd Internetional Conference on Biomedical Engineering , The 2nd Genetics and Genomics Conference and the 2nd Internetional Conference on Biomedical Engineering ; China, 2014; 59.      

9Dmitrijevs I.; Paramonova N.; Sjakste N.; Sjakste T. Association of the PSMA6 promoter Polya polymorphism with type I Diabetes mellitus /15/. Latvijas Universitātes 72. zinātniskās konferences Medīcīnas sekcijas Tēžu apkopojums, Latvijas Universitātes 72. zinātniskā konference, Medīcīnas sekcija; Rīga, Latvija, 2014; 80.      

10Paramonova N.; Sjakste T.; Shi-Shin Wu L.; Zemeckiene Z.; Sugoka O.; Sitkauskiene B.; Sakalauskas R.; Wang Jiu-Yao; Sjakste N. Genetic diversity of the PSMA6 (RS2277460, RS1048990), PSMC6 (RS2295826, RS2295827) and PSMA3 (RS2348071) genes in Latvian, Lithuanian and Taiwanese populations. /11/. Latvijas Universitātes 72. zinātniskās konferences Medīcīnas sekcijas Tēžu apkopojums, Latvijas Universitātes 72. zinātniskā konference, Medīcīnas sekcija; Rīga, Latvija, 2014; 30.      

11Buraka E.; Rostoka E.; Duburs G.; Sjakste N. 1,4-DHP ietekme uz peroksinitrīta sabrukšanas procesa ātrumu un to spēja pasargāt Šūnas DNS no peroksinitrīta izraisītajiem bojājumiem /6/. Latvijas Universitātes 72. zinātniskās konferences Medīcīnas sekcijas Tēžu apkopojums, Latvijas Universitātes 72. zinātniskā konference, Medīcīnas sekcija; Rīga, Latvija , 2014; 24.      

12Rostoka E.; Baumane L.; Šaripova J.; Duburs G.; Sjakste N. 1,4-DHP Antioksidatīvo un DNS Pasargājošo Īpašību Izvērtēšana in vitro /4/. Latvijas Universitātes 72. zinātniskās konferences Medīcīnas sekcijas Tēžu apkopojums, Latvijas Universitātes 72. zinātniskā konference, Medīcīnas sekcija; Rīga, Latvija, 2014; 20.      

13Sokolovska J.; Rostoka E.; Buraka E.; Sugoka O.; Isajevs S.; Baumane L.; Sharipova J.; Kalvins I.; Sjakste N. Nitric Oxide Hyperproduction and Markers of DNA Damage in the Early Phase of Diabetic Nephropathy in Rats Streptozotocin Diabetes Mellitus Model. /8/. Latvijas Universitātes 72. zinātniskās konferences Medīcīnas sekcijas Tēžu apkopojums, Latvijas Universitātes 72. zinātniskā konference, Medīcīnas sekcija; Rīga, Latvija, 2014; 27.      

14Paramonova N.; Sjakste T.; Rumba-Rozenfelde I.; Sjakste N. Association of the PSMB5 (rs11543947), PSMC5 (rs2295826, rs2295827) genes polymorphisms with obesity in the Latvian population. Biopolymers & Cell vol. 30, Supplementary 5, VII International Meeting from Molecular to Cellular Events in Human Pathologies; Riga, Latvia, 2014; 32.      

15Kalniņa J.; Paramonova N.; Sjakste N.; Sjakste T. Evaluation of the PSMB5 (rs11543947) and PSMA3 (rs2348071) gene polymorphisms on the association with multiple sclerosis in Latvians. Biopolymers & Cell vol. 30, Supplementary 5, VII International Meeting from Molecular to Cellular Events in Human Pathologies; Riga, Latvia, 2014; 10.      

16Dekante A.; Rostoka E.; Sokolovska J.; Baumane L.; Sjakste N. Parameters of the nitric oxide metabolism and DNA integrity in patients with type I diabetes mellitus. Biopolymers & Cell vol. 30, Supplementary 5, VII International Meeting from Molecular to Cellular Events in Human Pathologies; Riga, Latvia, 2014; 9.      

17Buraka E.; Rostoka E.; Duburs G.; Sjakste N. Acceleration of the peroxynitrite decomposition rate, DNA binding and oxidative stress reduction by 1,4-dihidropiridine derivatives. Biopolymers & Cell vol. 30, Supplementary 5, VII International Meeting from Molecular to Cellular Events in Human Pathologies; Riga, Latvia, 2014; 7.      

18Sokolovska J.; Dekante A.; Baumane L.; Rostoka E.; Sharipova J.; Sjakste N. Changes in nitric oxide metabolism in patients with different stages of diabetic nephropathy. . Abstract book - 29th Congress of the Federation of the International Danube Symposia on Diabetes Mellitus and 9th congress of central European diabetes association, 29th Congress of the Federation of the International Danube Symposia on Diabetes Mellitus and 9th congress of central European diabetes association; Riga, Latvia, 2014; 43.      

19Sokolovska J.; Rostoka E.; Buraka E.; Sugoka O.; Isajevs S.; Baumane L.; Sharipova J.; Kalvins I.; Sjakste N. Nitric oxide hyperproduction and markers of DNA damage in the early phase of diabetic nephropathy in rat streptozotocin diabetes mellitus model. . Abstract book - 27th European Diabetic nephropathy study group meeting (EDNSG) of the EASD, 27th European Diabetic nephropathy study group meeting (EDNSG) of the EASD; London, UK, 2014; 17.      

20Sokolovska J.; Rostoka E.; Buraka E.; Sugoka O.; Isajevs S.; Baumane L.; Sharipova J.; Kalvins I.; Sjakste N. Nitric oxide hyperproduction and markers of DNA damage in the early phase of diabetic nephropathy in rat streptozotocin diabetes mellitus model.. 50th annual meeting of EASD, , 50th annual meeting of EASD; Vienna, Austria: EASD virtual meeting: http://www.easdvirtualmeeting.org/resources/18152, 2014; 18152.      

21Bulgakova V.; Dambrova M.; Makarova E.; Vilskersts R.; Bevz A.; Prostyakov I.; Nadorov S.; Osipova E. The diference spectrum of activity of synthetic interferon inductors. /A553/. Arch Dis Child 2014; 99 (Suppl 2), The 5th Congress of the European Academy of Paediatric Societies EAPS ; Barcelona, Spain: Barcelona, Spain, 2014.      

22Zvejniece L.; Vavers E.; Svalbe B.; Domracheva I.; Vorona M.; Veinberg G.; Kalvinsh I.; Dambrova M. Allosteric modulator of Sigma–1 receptors enhance cognition and memory. . Basic & Clinical Pharmacology & Toxicology, 115 (Suppl. 1), The 17th World Congress of Basic and Clinical Pharmacology (WCP2014); Cape Town, South Africa: Cape Town, South Africa, 2014; 177.      

23Makrecka M.; Kuka J.; Volska K.; Dambrova M.; Liepinsh E. The accumulation of long chain acyl-carnitines determines the severity of cardiac ischemia-reperfusion injury.. Book of Abstracts - SHVM 2014 Twelfth annual scientific sessions - Strategies for recovering metabolic homeostasis and ventricular function in the diseased heart, SHVM 2014 Twelfth annual scientific sessions - Strategies for recovering metabolic homeostasis and ventricular function in the diseased heart; Tromso, Norway: Tromso, Norway, 2014; 43.      

24Kuka J.; Makrecka M.; Dambrova M.; Liepinsh E. Contents of long chain acyl-carnitines determine the pattern of energy metabolism in the heart. . Book of Abstracts - SHVM 2014 Twelfth annual scientific sessions - Strategies for recovering metabolic homeostasis and ventricular function in the diseased heart, Twelfth annual scientific sessions - Strategies for recovering metabolic homeostasis and ventricular function in the diseased heart - SHVM 2014 ; Tromso, Norway: Tromso, Norway, 2014; 37.      

25Peculis R.; Konrade I.; Skapare E.; Fridmanis D.; Nikitina-Zake L.; Lejnieks A.; Pirags V.; Dambrova M.; Klovins J. Decreased glyoxalase 1 activity caused by polymorphisms in GLO1 is gender dependent. . Book of Abstracts - The 29th Congress of the Federation of the International Danube Symposia on Diabetes mellitus, The 29th Congress of the Federation of the International Danube Symposia on Diabetes mellitus; Jurmala, Latvia: Jurmala, Latvia, 2014; 44.      

26Dambrova M.; Latkovskis G.; Strēle I.; Konrade I.; Grīnberga S.; Hartmane D.; Pugovics O.; Liepins J. Diabetes in patients undergoing percutaneous coronary intervention is associated with higher trimethylamine N-oxide plasma levels independently of carnitine. . Book of Abstracts - The 29th Congress of the Federation of the International Danube Symposia on Diabetes mellitus, The 29th Congress of the Federation of the International Danube Symposia on Diabetes mellitus; Jurmala, Latvia: Jurmala, Latvia, 2014; 39.      

27Vilskersts R.; Zharkova-Malkova O. ; Mezhapuke R.; Dambrova M. Elevated vascular gamma-butyrobetaine is protective in high glucose induced endothelial dysfunction. . Book of Abstracts, The 29th Congress of the Federation of the International Danube Symposia on Diabetes mellitus, The 29th Congress of the Federation of the International Danube Symposia on Diabetes mellitus; Jurmala, Latvia, 2014; 38.      

28Vilskersts R.; Kuka J.; Liepinsh E.; Gulbe A.; Dambrova M. Hypotensive Effects of Magnesium Nitrate in SHR Rats.. Basic & Clinical Pharmacology & Toxicology, 115 (Suppl. 1), The 17th World Congress of Basic and Clinical Pharmacology (WCP2014); Cape Town, South Africa: Cape Town, South Africa, 2014; 31.      

29Liepinsh E.; Makrecka M.; Kuka J.; Antonenko I.; Dambrova M. The heart is better protected against myocardial infarction in the fed state compared to the fasted state: role of insulin, glucose and fatty acids. . Basic & Clinical Pharmacology & Toxicology, 115 (Suppl. 1), The 17th World Congress of Basic and Clinical Pharmacology (WCP2014); Cape Town, South Africa: Cape Town, South Africa, 2014; 49.      

30Dambrova M.; Makrecka M.; Kuka J.; Vilskersts R.; Liepinsh E. Discovery of a novel regulator of cardiac energy metabolism, cardioprotective drug methyl-GBB.. Basic & Clinical Pharmacology & Toxicology, 115 (Suppl. 1), The 17th World Congress of Basic and Clinical Pharmacology (WCP2014), ; Cape Town, South Africa: Cape Town, South Africa, 2014; 19.      

31Kuznecovs J.; Vorona M.; Belyakov S.; Liepinsh E.; Petrova M.; Veinberg G. Regioselective Derivatization of 1-Acetyl-4-phenyl-2-pyrrolidone in Positions C3 and C5. Poster presentation 45. 8th Biennial International Conference on Organic Synthesis, 8th Biennial International Conference on Organic Synthesis; Vinius, Lithuania: Vinius, Lithuania, 2014; 45.      

32Veinberg G.; Vorona M.; Vavers E.; Zvejniece L.; Misane I.; Stonans I.; Kalvinsh I.; Dambrova M. Discovery of a novel positive allosteric modulator of sigma-1 receptor on the base of 4,5-disubstituted piracetam.. Book of Abstracts of the USA 34th National Medicinal Chemistry Symposium, 34th National Medicinal Chemistry Symposium of the USA ; Charlston, South Carolina USA: Charlston, South Carolina USA, 2014; 55.      

33Ворона М.; Орлова Н.; Кузнецов Е.; Кажока Х.; Беляков С.; Вейнберг Г. Стереоселективный синтез галогензамещенных 2-(2-нитро-1-фенилэтил)малонатов с помощью реакции Михаэля. . III Всероссийская конференция «Успехи химии и комплексообразования» Российский Университет дружбы народов, Тезисы докладов, III Всероссийская конференция «Успехи химии и комплексообразования» ; Российский Университет дружбы народов, Москва.: Москва., 2014; 52.      

34Kažoka H.; Veinberg G.; Vorona M. Direct separation of phenylpiracetam enantiomers on polysaccharide-based chiral stationary phases. /P527-SF-WE/. 30th International Symposium on Chromatography. in Final Program, ISC 2014., 30th International Symposium on Chromatography; Salzburg, Austria: Salzburg, Austria, 2014; 110.      

35Duburs G.; Bisenieks E.; Vigante B.; Beitnere U.; Isajevs S.; Klusa V. Adamantyl Group-Containing 1,4-Dihydropyridine Derivative Regulates Protein Expression Related to Synaptic Plasticity. /M005, P199/. 23th International Symposium on Medicinal Chemistry., 23th International Symposium on Medicinal Chemistry.; Lisbon, Portugal: Lisbon, Portugal, 2014.      

36Krasnova L.; Grinberga S.; Jaschenko E.; Shestakova I.; Adlere I.; Andzans Z.; Duburs G.; Krauze A. Synthesis of 3-Aminothieno[2,3-b]pyridines as Multidrug Resistance Modulators. Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells. COST Action CM1106, /P22/. 3rd Working Group Meeting. Budapest, 3rd Working Group Meeting. Budapest; Budapest, Hungary: Budapest, Hungary, 2014; 93.      

37Grinberga S.; Krasnova L.; Sokolova E.; Domracheva I.; Krauze A.; Shestakova I.; Duburs G. Thieno[2,3-b]pyridines - New Class of Mutidrug Resistance Modulators. /R016/. 23th International Symposium on Medicinal Chemistry. , 23th International Symposium on Medicinal Chemistry. ; Lisbon, Portugal: Lisbon, Portugal, 2014; 262.      

38Duburs G.; Krauze A.; Bisenieks E.; Vīgante B.; Plotniece A.; Brūvere I.; Grinberga S.; Shestakova I.; Domracheva I.; Jaschenko E.; Zarkovic N.; Molnar J. 1,4-Dihydropyridines and related Compounds as Potential Anticancer Drugs. /P158/. 9th International Conference of Anticancer Research., 9th International Conference of Anticancer Research.; Porto Carras, Sithonia, Greece: Porto Carras, Sithonia, Greece, 2014; 5890.      

39Ruciņš M.; Gosteva M.; Pajuste K.; Sobolevs A.; Cekavicus B.; Muceniece R.; Plotniece A. Antioksidantu un antiradikālo īpašību noteikšana oriģināliem bispiridil-1,4-dihidropiridīnu dibromīdiem. . Latvijas Universitātes 72. Zinātniskā konference. Medicīnas sekcija. Stenda ziņojumi, Tēžu apkopojums, Latvijas Universitātes 72. Zinātniskā konference; Rīga, LU: Rīga, LU, 2014; 63.      

40Rucins M.; Gosteva M.; Belyakov S.; Sobolev A.; Pajuste K.; Plotniece M.; Cekavicus B.; Tirzite D.; Plotniece A. Synthesis of novel bispyridinium-1,4-dihydropyridine dibromides and evaluation of their antiradical activity and reducing capacity. . 21st Young Research Fellow Meeting (XXIemes Journées Jeunes Chercheurs SCT), In Assets of Chemistry in Drug Discovery,, 21st Young Research Fellow Meeting (XXIemes Journées Jeunes Chercheurs SCT); Montpellier, France: Montpellier, France, 2014.      

41Cekavicus B.; Vigante B.; Rucins M.; Plotniece A.; Pajuste K.; Petrova M.; Belyakov S.; Duburs G.; Sobolev A. Cyclisation of benzo[b]thiophen-3(2H)-one 1,1-dioxide and 1,3- 1,4-indandione into novel methylene bridged polycyclic diazocines. /PO008/. In Program and Abstracts, International Conference on Organic Synthesis, Balticum Organicum Syntheticum (BOS-2014), in Program and Abstracts, , International Conference on Organic Synthesis, Balticum Organicum Syntheticum (BOS-2014); Vilnius, Lithuania: Vilnius, Lithuania, 2014; 52.      

42Rucins M.; Gosteva M.; Beliakov S.; Sobolev A.; Pajuste K.; Plotniece M.; Cekavicus B.; Tirzite D.; Plotniece A. Synthesis and studies of novel bispyridinium-1,4-dihydropyridine dibromides. /PO084/. International Conference on Organic Synthesis, Balticum Organicum Syntheticum (BOS-2014), in Programm and Abstracts, International Conference on Organic Synthesis, Balticum Organicum Syntheticum (BOS-2014); Vilnius, Lithuania: Vilnius, Lithuania, 2014; 128.      

43Plotniece A.; Gosteva M.; Rucins M.; Pajuste K.; Ose V.; Cekavicus B.; Vigante B.; Pajuste Kl.; Danne R.; Bandere D.; Duburs G.; Plotniece M.; Sobolev A. Synthesis of self-assembling cationic 1,4-dihydropyridines as delivery aģents for studies of structure-activity relationships. /PO074/. International Conference on Organic Synthesis, Balticum Organicum Syntheticum (BOS-2014), International Conference on Organic Synthesis, Balticum Organicum Syntheticum (BOS-2014); Vilnius, Lithuania: Vilnius, Lithuania, 2014; 118.      

44Jansone B.; Kadish I.; Groen T.; Beitnere U.; Plotniece A.; Ray-Moore D.; Pajuste K.; Klusha V. Cognition-enhancing effect of the novel 1,4-dihydropyridine derivative in male C57BL/6J mice. /FP3/. Word Congress on NeuroTherapeutics.in Congress programm,, Word Congress on NeuroTherapeutics; Basel, Switzerland: Basel, Switzerland, 2014; 37.      

45Plotniece A.; Gosteva M.; Pajuste K.; Rucins M.; Cekavicus B.; Pajuste Kl.; Plotniece M.; Ose V.; Petricenko O.; Vigante B.; Sobolev A. Structure-activity relationships for delivery agents on the scaffold of self-assembling cationic 1,4-dihydropyridines. /PA-11/. 28th Conference European Colloid and Interface Society, ECIS-2014, 28th Conference European Colloid and Interface Society, ECIS-2014; Limassol, Cyprus: Limassol, Cyprus, 2014; 13.      

46Muhamadejev R.; Petrova M.; Cekavicus B.; Plotniece A.; Duburs G.; Liepinsh E. Experimental and in silico studies of self-assembling cationic and phosphor lipids.. Abstracts of Riga Technical University the 55th International Scientific Conference, Section Material Science and Applied Chemistry, 55th International Scientific Conference of Riga Technical University, Section Material Science and Applied Chemistry; Riga, Latvia: Riga, 2014; 30.      

47Cekavicus B.; Plotniece M.; Plotniece A.; Danne R.; Sobolev A. Synthesis of novel methylene bridged polycyclic diazocines and their rearrangement into spirocyclic compounds. Abstracts of Riga Technical University the 55th International Scientific Conference, Section Material Science and Applied Chemistry, 55th International Scientific Conference of Riga Technical University, Section Material Science and Applied Chemistry; Riga, Latvia: Riga, 2014; 29.      

48Plotniece M.; Gosteva M.; Ose V.; Pajuste Kl.; Rucins M.; Cekavicus B.; Sobolev A.; Plotniece A. The influence of substituent on physical-chemical properties of 1,4-dihydropyridines as delivery agents. . Abstracts of Riga Technical University the 55th International Scientific Conference, Section Material Science and Applied Chemistry,, the 55th International Scientific Conference of Riga Technical University, Section Material Science and Applied Chemistry; Riga, Latvia: Riga, 2014; 28.      

49Kalvinš I. Latvian Institute of Organic Synthesis: stairway to excellence in medicinal chemistry and innovation. . Workshop, Application of biomaterials and in vivo imaging in stem cell research; Zagreb: Zagreb, 2014; 41.      

50Mierina I.; Jure M.; Zeberga S.; Mishnev A.; Zicane D.; Tetere Z.; Ravina I. Arylmethyl Derivatives of Meldrum's Acid - a New Class of Antioxidants. 12th Euro Fed Lipid Congress. Oils, Fats and Lipids: From Lipidomics to Indystrial Innovation, 12th Euro Fed Lipid Congress.; Montpellier, France12th Euro Fed Lipid Congress: Montpellier, France, 2014; 486.      

51Stepanovs D.; Jure M.; Mishnev A. Coformer selection in Pharmaceutical Cocrystal Engineering: a Case Study of a Pentoxifylline Aspirin Cocrystal. . COINS, COINS; Vilnius, Lithuania: Vilnius, Lithuania, 2014; 44.      

52Grehov V.; Kalnacs J.; Vilken A.; Mishnev A.; Chikvaidze G.; Knite M.; Saharov D. Graphene Nanosheets Grown on Ni Particles. . RCBJSF–2014–FM&NT Symposium, FM&NT Symposium; Riga, Latvia: Riga, Latvia, 2014; 303.      

53Петухов В.И.; Баумане Л.Х.; Дмитриев Е.В.; Романова М.А.; Щуков А.Н.; Ванин А.Ф. Завасит ли функциональная состоятельность нитроксида от синхронной работы осцилляторных (NO+)–генерирующих систем? = Is there any dependence between the functional ability of nitric oxide and synchronous work of oscillator NO+-generating systems?. Труды ХХII Международной конференции и дискуссионного научного клуба Новые информационные технологии в медицине, биологии, фармакологии и экологии,, Новые информационные технологии в медицине, биологии, фармакологии и экологии, = New Information Technology in Medicine, Pharmacology; Ялта-Гурзуф, Крым, УкраинаТруды ХХII Международной конференции: Крым, Украина, 2014; 110.      

54Goba I.; Liepins Edvards Spectroscopic and conformational analysis of symmetrical and unsymmetrical 1,4- dihydroisonicotinic acid derivatives. Euromar 2014, Magnetic Resonance Conference, Small Molecules and Pharmaceuticals; ETH Zurich: Switzerland, 2014; 202.      

55Plotniece A.; Gosteva M.; Pajuste Kl.; Rucins M.; Cekavicus B.; Pajuste Kl.; Plotniece M.; Ose V.; Petrichenko O. ; Vigante B.; Sobolev A. Structura-Activity Relationships for Delivery Agents on the Scaffold of Self-Assembling Cationic 1,4-Dihydropyridines. Poster Presentations Abstracts, ECIS2014. 28th Conference of the European Colloid and Interface Society ; PA-11. September 7-12: Limassol, Ciprus, 2014; 13.      

56Петухов В.И.; Баумане Л.Х.; Ванин А.Ф. Клиническая симптоматика сидеропенического синдрома - свидетельство функциональной несостоятельности оксида азота. Сборник статей Одиннадцатого съезда Белорусского общественного объединения фотобиологов и биофизиков. Часть 2. Молекулярные, мембранные и клеточные основы функционирования биосистем, 17-20 июня : Минск, Белорусь, 2014; 279.      

57Sevostjanovs E.; Grinberga S.; Pugovics O.; Liepins E. Simultaneous determination of acylcarnitines and acylcoenzyme A,s in rat heart tissue homogenate samples by UPLC-MS-MS. NoSSS - Nordic Separation Science Society, 7th Symposium - Advances in separation science (Part I), 9-11 June (www.analysdagarna.se): Djurönäset near Stockholm, Sweden, 2014.      

58Kažoka H.; Veinberg G.; Vorona M. Normal phase enantioseparation of phenylpiracetam derivatives on polysaccharide-based chiral stationary phases. NoSSS - Nordic Separation Science Society, 7th Symposium Advances in separation science (Part I), 9-11 June (www.analysdagarna.se): Djurönäset near Stockholm, Sweden, 2014.      

59Arsenyan P.; Vasiljeva J.; Paegle E. Selenium bromide as a key for the preparation of novel pharmacomodulators. Programme Book, 15th Tetrahedron Symposium Challenges in Bioorganic and Organic Medicinal Chemistry (www.tetrahedron-symposium.elsevier.com); 24 - 27th June: [P3.20]. London, UK, 2014.      

60Stepanovs D.; Jure M.; Mishnev A. Conformer selection in Pharmaceutical Cocrystal Engineering: a Case of a Pentoxifylline Aspirin Cocrystal. COINS Conference of Natural and Life sciences, , 2014; 44.      

61Orlova N.; Vorona M.; Belyakov S.; Petrova M.; Kazoka H.; Veinberg G. Stereoselective Michael Addition of Malonates to B-Substituted B-Nitrostyrenes. Program and Abstract Book, 8th Biennial International Conference on Organic Synthesis Balticum Organicum Syntheticum; July 6-9: PO68. Vilnius (Lithuania), 2014.      

62Nikitjuka A.; Nekrasova A.; Jirgensons A. Acid-labile Methylprenyl Protection for Sulfonamides. Program and Abstract Book, 8th Biennial International Conference on Organic Synthesis Balticum Organicum Syntheticum; July 6-9: PO64. Vilnius (Lithuania), 2014.      

63Novosjolova I.; Stepanovs D.; Bizdēna Ē.; Mishnev A.; Turks M. Synthetic Applications of 2,6-Diazidopurine Nucleosides Leading to Modified Triazolylpurine Derivatives. Program and Abstract Book, 8th Biennial International Conference on Organic Synthesis Balticum Organicum Syntheticum; July 6-9: PO66. Vilnius (Lithuania), 2014; 110.      

64Spura J.; Domrachova I.; Shestakova I.; Popelis J.; Ignatovich L. Synthesis and cytotoxicity of Organylsilyl(germyl)hetaryl ketoximes. Program. Abstracts. ISOS XVII. The 17th International Symposium on Silicon Chemistry, August 3-8: PO-203. Berlin (Germany), 2014; 239.      

65Ryabova V.; Sleiksha I.; Muravenko V.; Belyakov S.; Shestakova I.; Ignatovich L. Preparation, Structure and Cytotoxic Activity of Hetarylsilanes and -silatranes. Program. Abstracts. ISOS XVII. The 17th International Symposium on Silicon Chemistry, August 3-8: PO-192. Berlin (Germany), 2014; 233.      

66Ignatovich L.; Romanovs V.; Muravenko V.; Sleiksha I.; Shestakova I. 5-Organylsilyl(germyl)-2-Furylaminopropylsilacycles. Program. Abstracts. ISOS XVII. The 17th International Symposium on Silicon Chemistry, August 3-8: PO-190. Berlin (Germany), 2014; 232.      

67Ignatovich L.; Muravenko V.; Spura J.; Belyakov S.; Shestakova I. Synthesis, Structure and Biological Activity of 4-Organylsilyl(germyl)hetaryl-3-cyano-6,6-dimethyl-5,6-dihydro-2-pyranones. Program. Abstracts. ISOS XVII. The 17th International Symposium on Silicon Chemistry, August 3-8: PO-96. Berlin (Germany), 2014; 183.      

68Svalbe B.; Zvejniece L.; Makrecka M.; Volska K.; Dambrova M.; Liepinsh E. Reduced content of acyl-carnitines protects mitochondrija against anoxia-reoxygenation. 8th Symposium on Neuroprotection and Neurorepair, 9-12 April: Magdeberg Meeting Series, Germany, 2014.      

69Zvejniece L.; Vavers E.; Svalbe B.; Dambrova M. R-Phenibut treatment improves functional recovery following ischemic stroke in rats. 8th Symposium on Neuroprotection and Neurorepair, 9-12 April: Magdeberg Meeting Series, Germany, 2014.      

70Makrecka M.; Kūka J.; Voļska K.; Dambrova M.; Liepiņš E. Garķēžu acil-karnitīnu loma enerģijas metabolisma regulācijā un sirds išēmijas-reperfūzijas bojājuma attīstībā . RSU zinātniskā konference. II sekcija: Latvijas iedzīvotāju veselību apdraudošo eksogēno un endogēno faktoru izpēte, 10. un 11. aprīlī: RĪga, Latvija, 2014; 70.      

71Konrāde I.; Makrecka M.; Kalere I.; Jēkabsone A.; Tetere E.; Sokolova J.; Strēle I.; Veisa V.; Rezeberga D; Lejnieks A.; Dambrova M. Nepietiekams nodrošinājums ar jodu grūtniecēm Latvijā . RSU zinātniskā konference. II sekcija: Latvijas iedzīvotāju veselību apdraudošo eksogēno un endogēno faktoru izpēte, 10. un 11. aprīlī; : Rīga, Latvija, 2014; 121.      

72Vilšķērsts R.; Žarkova-Malkova O.; Mežapuķe R.; Bandere D.; Dambrova M. Gamma-butirobetaīna vazoprotektīvie efekti eksperimentālajos in vitro modeļos . RSU zinātniskā konference. II sekcija: Latvijas iedzīvotāju veselību apdraudošo eksogēno un endogēno faktoru izpēte , 10. un 11. aprīlī: RĪga, Latvija, 2014; 79.      

73Vāvers E.; Zvejniece L.; Švalbe B.; Domračeva I.; Vilšķērsts R.; Dambrova M. Sigma-1 receptoru pozitīva alostēriska modulēšana uzlabo kognitīvo funkciju . RSU zinātniskā konference. II sekcija: Latvijas iedzīvotāju veselību apdraudošo eksogēno un endogēno faktoru izpēte , 10. un 11. aprīlī: Rīga, Latvija, 2014; 89.      

74Neimane L.; Makrecka M.; Strēle I.; Lejnieks A.; Vēvere P.; Zariņa I.; Dambrova M.; Konrāde I. Nepietiekams iedzīvotāju nodrošinājums ar jodu Latgalē un Vidzemē . RSU zinātniskā konference. II sekcija: Latvijas iedzīvotāju veselību apdraudošo eksogēno un endogēno faktoru izpēte, 10. un 11. aprīlī: RĪga, Latvija, 2014; 116.      

75Pajuste Kl.; Pajuste K.; Ruciņš M.; Gosteva M.; Domračeva I.; Šestakova I.; Plotniece M.; Bandere D.; Plotniece A. Stirilpiridīnija grupu saturošu 1,4-dihidropiridīna atvasinājumu sintēze un īpašību izpēte. RSU Zinātniskā konference. Tēzes II, 10.-11. aprīlis: Rīga,, 2014; 81.      

76Dambrova M.; Vavers E.; Zvejniece L. The cognition-enhancing activity of EIR, a novel positive allosteric modulator of sigma-1 receptors. Workshop, Application of biomaterials and in vivo imaging in stem cell research; March 27-29: Zagreb, 2014; 43.      

77Rucins M.; Gosteva M.; Belyakov S.; Sobolev A.; Pajuste K.; Plotniece M.; Cekavicus B.; Tirzite D.; Plotniece A. Synthesis of novel bispyridinium-1,4-dihydropyridine dibromides and evaluation of their antiradical activity and reducing capacity. Assets of Chemistry in Drug Discovery, 21st Young Research Fellow Meeting (XXIemes Journées Jeunes Chercheurs SCT) ; 24–25 March: PO-58. Montpellier, France, 2014.      

78Dmitrijevs I.; Paramonova N.; Sjakste N.; Sjakste T. Association of the PSMA6 promoter polyA polymorphism with Type I Diabetes Mellitus. Tēžu apkopojums, Latvijas Universitātes 72. Zinātniskā konference. Medicīnas sekcija. Stenda ziņojumi; 14. februarī: Rīga, LU, 2014; 80.      

79Paramonova N.; Sjakste T.; Wu Lawrence Shi-Shin; Zemeckiene Z.; Sugoka O.; Sitkauskiene B.; Sakalauskas R.; Wang Jiu-Yao; Sjakste N. Genetic diversity of the PSMA6 (RS2277460, RS1048990), PSMC6 (RS2295826, RS2295827) and PSMA3 (RS2348071) genes in Latvian, Lithuanian and Taiwanese populations. Tēžu apkopojums, Latvijas Universitātes 72. Zinātniskā konference. Medicīnas sekcija; 14. februarī: Rīga, LU, 2014; 30.      

80Sokolovska J.; Rostoka E.; Buraka E.; Sugoka O.; Isajevs S.; Baumane L.; Sharipova J.; Kalvins I.; Sjakste N. Nitric oxide hyperproduction and markers of DNA damage in the early phase of diabetic nephropathy in rat streptozotocin diabetes mellitus model . Tēžu apkopojums, Latvijas Universitātes 72. Zinātniskā konference. Medicīnas sekcija; 14. februarī: Rīga, LU, 2014; 27.      

81Švalbe B.; Makrecka M.; Voļska K.; Cīrule H.; Muceniece R.; Dambrova M. 1-Karnitīna biosintēzes inhibitora mildronāta ietekme uz smadzeņu mitohondriju funkciju. Tēžu apkopojums, Latvijas Universitātes 72. Zinātniskā konference. Medicīnas sekcija; 14. februarī: Rīga, LU, 2014; 22.      

82Ruciņš M.; Gosteva M.; Pajuste K.; Soboļevs A.; Čekavičus B.; Muceniece R.; Plotniece A. Antioksidantu un antiradikālo īpašību noteikšana oriģināliem bispiridil-1,4-dihidropiridīnu dibromīdiem. Tēžu apkopojums, Latvijas Universitātes 72. Zinātniskā konference. Medicīnas sekcija. Stenda ziņojumi; 14. februarī: Rīga, LU, 2014; 63.      

83Isajevs S.; Sokolovska J.; Sjakste N. Xantine oxidase and NO synthase expression in kidney tissue of streptozotocin-induced diabetic rats. Virchows Archiv (2013) 463:101-352. The European Journal od Pathology, 25th European Congress of Pathology; 30 August - 3 September: London, United Kingdom, 2014; 296.      

Disertācijas
84Maleckis A. Reactivity Studies of Catalytically Relevant Palladium Model Complexes. Promocijas darbs ķīmijas zinātņu doktora grāda iegūšanai (PhD), The University of Michigan, Mičigana, ASV, 2014.      

85Toleikis Zigmantas. Structure of Leptin Receptor Related with Obesity. Promocijas darbs bioķīmijas zinātņu doktora grāda iegūšanai (Phd), Kopenhāgenas Universitāte, Kopenhāgena, Dānija, 2014.      

86Švalbe B. L-karnitīna biosintēzes inhibitora mildronāta neirotropo efektu pētījumi. Promocijas darbs farmācijas zinātņu doktora grāda iegūšanai (Dr.pharm.), Latvijas Universitāte, Rīga, 2014.      

87Supe L. Design and Synthesis of 1H-Pyrazolo[3,4-b]Pyridin-3(2H)-ones and Corresponding N-Nucleosides-New Purine Isosters as Potential druglike Scaffolds. Promocijas darbs ķīmijas zinātņu doktora grāda iegūšanai (Dr.chem.), Rostokas Universitāte, Vācija, 2014.      

88Pelšs A. Practical methodologies for amino alcohol based natural products synthesis. Promocijas darbs ķīmijas zinātņu doktora grāda iegūšanai (Dr.chem.), Aalto University, Somija, 2014.      

89Kher S.S. Malārijas proteāzes PfSUB1 inhibitoru izstrāde. Promocijas darbs ķīmijas zinātņu doktora grāda iegūšanai (Dr.chem.), Rīgas Tehniskā Universitāte, Rīga , 2014.      

90Andžāns Z. Optiski aktīvu 1,4-dihidropiridīn-6-sulfanilalkilkarbonskābju esteru sintēze un īpašības. Promocijas darbs ķīmijas doktora grāda iegūšanai (Dr.chem.), Latvijas Universitāte, Rīga, 2014.      

Scopus datu bāzē indeksētās publikācijas
91*Uchuskin M.G.; Molodtsova N.V.; Lysenko S.A.; Strel'Nikov V.N.; Trushkov I.V.; Butin A.V. Synthesis of indoles by domino reaction of 2-(tosylamino)benzyl alcohols with furfurylamines: Two opposite reactivity modes of the α-carbon of the furan ring in one process. Eur. J. Org. Chem. 2014, 2014(12), 2508-2515.      

92Butin A.V.; Lyzhov O.V.; Kim V.A.; *Murav'ev V.I.; Belova I.V. Quantitative Evaluation of Steel 15Kh5M Structural Degradation in a Stressed State and with Thermal Exposure. Chem. Pet. Eng. 2014, 49(9-10), 629-634.      

93Gataeva O.K.; *Abaev V.T.; Kolodina A.A.; Butin A.V. Simple method for the synthesis of aryl(furfuryl)glyoxals. Chem. Heterocycl. Compd. 2014, 50(2), 296-299.      

94Butin A.V.; Trushkov I.V.; Serdyuk O.V.; Abaev V.T. Fluorinated furans and benzofurans. Fluor. in Heterocyclic Chemistry: Volume 1: 5-Membered Heterocycles and Macrocycles 2014, 181-231.      

95Serdyuk O.V.; Abaev V.T.; Butin A.V.; Nenajdenko V.G. Fluorinated thiophenes and their analogues. Fluor. in Heterocyclic Chemistry: Volume 1: 5-Membered Heterocycles and Macrocycles 2014, 233-277.      

96Uchuskin M.G.; Shcherbinin V.A.; *Butin A.V. Synthesis and transformations of naphtho[2,3-b]furans (review). Chem. Heterocycl. Compd. 2014, 50(5), 619-633.      

97*Voskressensky L.G.; Voskressensky L.G.; Borisova T.N.; Babakhanova M.I.; Titov A.A.; Chervyakova T.M.; Novikov R.A.; Butin A.V.; Khrustalev V.N.; Varlamov A.V. Transformation of 4-substituted tetrahydro-pyrrolobenzodiazepines in a three-component reaction with methyl propiolate and indole. Chem. Heterocycl. Compd. 2014, 49(12), 1785-1794.      

98Sustere Z.; Kampare R.; Liepiņš E.; Kampars V. The composition of commercial acetylated glycerol samples determined by 13C and 1H NMR. the comparison with gas chromatography. J. Anal. Chem. 2014, 69(8), 763-768.      

99Mykhaylychenko S.S.; Pikun N.V.; Rusanov E.B.; *Shermolovich Y.G. Synthesis of fluorine-containing 1,3-thiazine derivatives from primary polyfluoroalkanethioamides. J. Fluor. Chem. 2014, 168, 105-110.      

100*Konrāde I.; Neimane L.; Makrecka M.; Strele I.; Liepinsh E.; Lejnieks A.; Vevere P.; Gruntmanis U.; Pīrāgs V.; Dambrova M. A cross-sectional survey of urinary iodine status in Latvia. Medicina 2014, 50(2), 124-129.      

101Podjava A.; Kistkin S.; Ausekle E.; Priede E.; Mekss P.; Zicmanis A. Electrospray ionization mass spectrometry of non-covalent complexes formed between N-alkylimidazolium-containing zwitterionic sulfonates and protonated bases. Eur. J. Mass Spectrom. 2014, 20(6), 467-475.      

102Vendiņa I.; Parkova A.; *Trapencieris P. o-directed lithiation of acylated hydroxythiophenes. Heterocycles 2014, 8(2), 1565-1572.      

103*Sjakste T.; Paramonova N.; Wu L.S.; Zemeckiene Z.; Sitkauskiene B.; Sakalauskas R.; Wang J.-Y.; Sjakste N. PSMA6 (rs2277460, rs1048990), PSMC6 (rs2295826, rs2295827) and PSMA3 (rs2348071) genetic diversity in Latvians, Lithuanians and Taiwanese. Meta Gene 2014, 2(1), 283-298.      

104Paramonova N.; Wu L.S.S.; Rumba-Rozenfelde I.; Wang J.-Y.; Sjakste N.; Sjakste T. Genetic variants in the PSMA6, PSMC6 and PSMA3 genes associated with childhood asthma in Latvian and taiwanese populations. Bioplym. Cell 2014, 30(5), 377-387.      

105Paramonova N.; Kupca S.; Rumba-Rozenfelde I.; Sjakste N.; Sjakste T. Association between the PSMB5 and PSMC6 genetic variations and children obesity in the Latvian population. Bioplym. Cell 2014, 30(6), 477-480.      

106Kalnina J.; Paramonova N.; Sjakste N.; Sjakste T. Study of association between polymorphisms in the psmb5 (Rs11543947) and psma3 (rs2348071) genes and multiple sclerosis in latvians. Bioplym. Cell 2014, 30(4), 305-309.      

107Peipins U.; Freimanis N.; Stepanovs D.; Mishnev A.; *Turks M. Betulin 3,28-di-O-tosylate. Acta Crystallogr. Sect. E Struct. Rep. Online 2014, 70(8).      

108Vigante B.; *Stepanovs D.; Pelšs A.; Mishnev A. Crystal structure of 3-amino-5,5-dimethyl-2-[(E)-2-nitroethenyl]cyclohex-2-en-1-one. Acta Crystallogr. Sect. E Struct. Rep. Online 2014, 70(11), 379-381.      

109*Mishnev A.; Stepanovs D. Crystal structure explains crystal habit for the antiviral drug rimantadine hydrochloride. Z. Naturforsch. Sect. B J. Chem. Sci. 2014, 69(7), 823-828.      

110*Terentjeva S.; Muceniece D.; Lūsis V. Preparation of 6-unsubstituted 3,4-dihydropyrimidin-2(1H)-ones and 2-(arylamino)pyrimidines. Chem. Heterocycl. Compd. 2014, 49(12), 1757-1769.      

111*Loča D.; Sevostjanovs E.; Makrecka M.; Zharkova-Malkova O.; Berzina-Cimdina L.; Tupureina V.; Sokolova M. Microencapsulation of mildronate in biodegradable and non-biodegradable polymers. J. Microencapsulation 2014, 31(3), 246-253.      

112*Garaliene V.; Barsys V.; Giedraitis S.; Benetis R.; Krauze A. The role of external Ca2+ in the action of Ca2+ - Channel agonists and antagonists on isolated human thoracic arteries. J. Physiol. Pharmacol. 2014, 65(1), 25-31.      

113*Kodolins O.; Lūsis V.; Muceniece D. Synthesis and reactions of methyl 8-aryl-6-methyl-9-oxo-8,9-dihydro-5H-dibenzo[4,5:6,7]cyclohepta[1,2-b]pyridine-7-carboxylates. Chem. Heterocycl. Compd. 2014, 50(9), 1270-1279.      

114*Rjabovs V.; Mishnev A.; Kiseļovs G.; Turks M. {(3aR,5S,6R,6aR)-5-[(R)-1,2-dihydroxyethyl]-2,2-dimethyltetrahydrofuro[2, 3-d][1,3]dioxol-6-yl}methyl methanesulfonate. Acta Crystallogr. Sect. E Struct. Rep. Online 2014, 70(5).      

115Vanejev M.O.; Teus M.V.; *Kauss V. Preparation of 2-azabicyclo[3.3.1]nonan-3-ones by a radical c-carbonylation of methylcyclo-hexylamines. Chem. Heterocycl. Compd. 2014, 49(10), 1537-1540.      

116Kronqvist N.; Otikovs M.; Chmyrov V.; Chen G.; Andersson M.; Nordling K.; Landreh M.; Sarr M.; Jornvall H.; Wennmalm S.; Widengren J.; Meng Q.; Rising A.; Otzen D.; Knight S.D.; Jaudzems K.; Johansson J. Sequential pH-driven dimerization and stabilization of the N-terminal domain enables rapid spider silk formation. Nat. Commun. 2014, 5, 3254.      

117De Simone G.; Pizika G.; Monti S.M.; Di Fiore A.; Ivanova J.; Vozny I.; Trapencieris P.; *Žalubovskis R.; Supuran C.T.; Alterio V. Hydrophobic Substituents of the Phenylmethylsulfamide Moiety Can Be Used for the Development of New Selective Carbonic Anhydrase Inhibitors. BioMed Res. Int. 2014, 2014.      

118Morkunaite V.; Baranauskiene L.; Zubriene A.; Kairys V.; Ivanova J.; Trapencieris P.; *Matulis D. Saccharin Sulfonamides as Inhibitors of Carbonic Anhydrases I, II, VII, XII, and XIII. BioMed Res. Int. 2014, 2014.      

119*Kazaks A.; Makrecka-Kuka M.; Kūka J.; Voronkova T.; Akopjana I.; Grinberga S.; Pugovičs O.; Tars K. Expression and purification of active, stabilized trimethyllysine hydroxylase. Protein Expr. Purif. 2014, 104, 1-6.      

120Ruciņš M.; Kaldre D.; Pajuste K.; Fernandes M.A.S.; Vicente J.A.F.; Klimaviciusa L.; Jaschenko E.; Kanepe-Lapsa I.; Shestakova I.; Plotniece M.; Gosteva M.; Sobolev A.; Jansone B.; Muceniece R.; *Kluša V.; Plotniece A. Synthesis and studies of calcium channel blocking and antioxidant activities of novel 4-pyridinium and/or N-propargyl substituted 1,4-dihydropyridine derivatives. C. R. Chim. 2014, 17(1), 69-80.      

121*Dambrova M.; Makrecka M.; Vilšķērsts R.; Kūka J.; Liepinsh E. Carnitine As A Marker Of Atherosclerosis And Other Risks Of Cardiovascular Diseases. Kardiologiia 2014, 54(8), 91-96.      

122*Liepinsh E.; Makrecka M.; Kūka J.; Cīrule H.; Makarova E.; Sevostjanovs E.; Grinberga S.; Vilšķērsts R.; Loļa D.; Loža E.; Stonans I.; Pugovičs O.; Dambrova M. Selective inhibition of OCTN2 is more effective than inhibition of gamma-butyrobetaine dioxygenase to decrease the availability of l-carnitine and to reduce myocardial infarct size. Pharmacol. Res. 2014, 85, 33-38.      

123Razafimahefa S.; Mutulis F.; Mutule I.; Liepinsh E.; Dambrova M.; Cīrule H.; Švalbe B.; Yahorava S.; Yahorau A.; Rasolondratovo B.; Rasoanaivo P.; *Wikberg J.E.S. Libiguins A and B: Novel phragmalin limonoids isolated from neobeguea mahafalensis causing profound enhancement of sexual activity. Planta Med. 2014, 80(4), 306-314.      

124*Liepinsh E.; Makrecka M.; Kūka J.; Makarova E.; Vilšķērsts R.; Cīrule H.; Sevostjanovs E.; Grinberga S.; Pugovičs O.; Dambrova M. The heart is better protected against myocardial infarction in the fed state compared to the fasted state. Metab. Clin. Exp. 2014, 63(1), 127-136.      

125*Vilšķērsts R.; Kūka J.; Liepinsh E.; Cīrule H.; Gulbe A.; Kalvinsh I.; Dambrova M. Magnesium nitrate attenuates blood pressure rise in SHR rats. Magnes. Res. 2014, 27(1), 16-24.      

126Chernyak D.; Ponomaryov Y.; Varacheva L.L.; *Lebedev A.; Chernobroviy A. Employment of the TiCl4-anisole-pyridine system in the condensation of amides with aromatic amines. Chem. Heterocycl. Compd. 2014, 50(9), 1354-1357.      

127*Petrova M.; Muhamadejev R.; Čekavičus B.; Vigante B.; Plotniece A.; Sobolev A.; Duburs G.; Liepinsh E. Experimental and theoretical studies of bromination of diethyl 2,4,6-Trimethyl-1,4-dihydropyridine-3,5-dicarboxylate. Heteroatom Chem. 2014, 25(2), 114-126.      

128*Brangulis K.; Petrovskis I.; Kazaks A.; Bogans J.; Otikovs M.; Jaudzems K.; Ranka R.; Tars K. Structural characterization of CspZ, a complement regulator factor H and FHL-1 binding protein from Borrelia burgdorferi. FEBS J. 2014, 281(11), 2613-2622.      

129Anusevicius K.; *Mickevicius V.; Belyakov S.; Siugzdaite J.; Kantminiene K. Unexpected transformation of ethyl 1-(4-chlorophenyl)-2-methyl-4-oxo-1,4,5,6-tetrahydropyridine-3-carboxylate and antibacterial activity of the products. Monatsh. Chem. 2014, 145(10), 1611-1620.      

130*Sarceviča I.; Orola L.; Veidis M.V.; Belyakov S. Cinnamic acid hydrogen bonds to isoniazid and N'-(propan-2-ylidene) isonicotinohydrazide, an in situ reaction product of isoniazid and acetone. Acta crystallogr., C Struct. Chem. 2014, 70(4), 392-395.      

131Zhao P.; Hu H.; Gvishi R.; Strum G.; Tal A.; Grinvald S.; Bar G.; Beķere L.; Lokshin V.; Khodorkovsky V.; Sigalov M.; Hagan D.; Van Stryland E. Förster resonance energy transfer within a donor-acceptor composite photochromic molecule through one- and two-photon absorption. Opt.InfoBase Conf. Papers 2014.      

132Gvishi R.; Zhao P.; Hu H.; Strum G.; Tal A.; Grinvald S.; Bar G.; Beķere L.; Lokshin V.; Khodorkovsky V.; Sigalov M.; Hagan D.; Van Stryland E. Nonlinear solid-state filter based on photochromism induced by 2-photon absorption in a dye-doped sol-gel. Proc SPIE Int Soc Opt Eng 2014, 9181.      

133Zhao P.; Hu H.; Gvishi R.; Strum G.; Tal A.; Grinvald S.; Bar G.; Beķere L.; Lokshin V.; Khodorkovsky V.; Sigalov M.; Hagan D.; Van Stryland E. Förster resonance energy transfer within a donor-acceptor composite photochromic molecule through oneand two-photon absorption. Conf Lasers Electro Opt Eur Tech Dig 2014, 2014-January.      

134*Zarins A.; Kizane G.; Supe A.; Knitter R.; Kolb M.H.H.; Tiliks Jr. J.; Baumane L. Influence of chemisorption products of carbon dioxide and water vapour on radiolysis of tritium breeder. Fusion Eng Des 2014, 89(7-8), 1426-1430.      

135*Petukhov V.I.; Baumane L.K.; Dmitriev E.V.; Vanin A.F. Nitric oxide and electrogenic metals (Ca, Na, K) in epidermal cells. Biochem. (Moscow) Suppl. Ser. B Biomed. Chem. 2014, 8(4), 343-348.      

136*Arsenyan P.; Vasiļjeva J.; Belyakov S. Preparation of conjugated 6,6'-bibenzo[b]selenophenes. Mendeleev Commun. 2014, 24(1), 32-34.      

137Paegle E.; Belyakov S.; *Arsenyan P. An approach to the selenobromination of aryl(thienyl)alkynes: Access to 3-bromobenzo[b]selenophenes and selenophenothiophenes. Eur. J. Org. Chem. 2014, 2014(18), 3831-3840.      

138*Makrecka M.; Kūka J.; Volska K.; Antone U.; Sevostjanovs E.; Cīrule H.; Grinberga S.; Pugovičs O.; Dambrova M.; Liepinsh E. Long-chain acylcarnitine content determines the pattern of energy metabolism in cardiac mitochondria. Mol. Cell. Biochem. 2014, 395(1-2), 1-10.      

139Platace R.; Adamovics A.; Antone U. Combustion ability of energy crop pellets: Assessment and future perspectives. Int. Multidisciplinary Sci. Geoconf. Surveying Geology Mining Ecology Manage., SGEM 2014, 1(4), 109-116.      

140*Ābele E.; Abele R. Recent advances in the Synthesis of heterocycles from oximes. Curr. Org. Synth. 2014, 11(3), 403-428.      

141Ye B.; Donets P.A.; *Cramer N. Chiral Cp-rhodium(III)-catalyzed asymmetric hydroarylations of 1,1-disubstituted alkenes. Angew. Chem. Int. Ed. 2014, 53(2), 507-511.      

142Mackevica J.; Ostrovskis P.; Leffler H.; Nilsson U.J..; Rudovica V.; Viksna A.; Belyakov S.; *Turks M. Synthesis of 1,2,3-triazole-linked galactohybrids and their inhibitory activities on galectins. Arkivoc 2014, 2014(3), 90-112.      

143Štrumfs B.; Hermane J.; Belyakov S.; *Trapencieris P. Acyl migration from N to C in aziridine-2-carboxylic esters. Tetrahedron 2014, 70(2), 355-362.      

144*Zhulenkovs D.; Jaudzems K.; Zajakina A.; Leonchiks A. Enzymatic activity of circular sortase A under denaturing conditions: An advanced tool for protein ligation. Biochem. Eng. J. 2014, 82, 200-209.      

145*Makrecka M.; Švalbe B.; Volska K.; Sevostjanovs E.; Liepins J.; Grinberga S.; Pugovičs O.; Liepinsh E.; Dambrova M. Mildronate, the inhibitor of l-carnitine transport, induces brain mitochondrial uncoupling and protects against anoxia-reoxygenation. Eur. J. Pharmacol. 2014, 723(1), 55-61.      

146*Andžāns Z.; Adlere I.; Veršilovskis A.; Krasnova L.; Grīnberga S.; Duburs G.; Krauze A. Effective method of lipase-catalyzed enantioresolution of 6-alkylsulfanyl-1,4-dihydropyridines. Heterocycles 2014, 89(1), 43-58.      

147Capligina V.; Salmane I.; Keiss O.; Vilks K.; Japina K.; Baumanis V.; *Ranka R. Prevalence of tick-borne pathogens in ticks collected from migratory birds in Latvia. Ticks Tick-borne Dis. 2014, 5(1), 75-81.      

148*Veinberg G.; Potoročina I.; Vorona M. Recent trends in the design, synthesis and biological exploration of β -lactams. Curr. Med. Chem. 2014, 21(4), 393-416.      

149*Novosjolova I.; Stepanovs D.; Bizdēna Ē.; Mishnev A.; Turks M. 2,6-Dichloro-9-(2′,3′,5′-tri-O-acetyl-β-d- ribofuranosyl)-9H-purine. Acta Crystallogr. Sect. E Struct. Rep. Online 2014, 70(2).      

150Muceniece D.; Kodolins O.; *Lūsis V. Synthesis of 2-arylaminopyrimidines from 1,4,6-Trisubstituted Pyrimidine-2(1H)-thiones. Chem. Heterocycl. Compd. 2014, 49(11), 1658-1666.      

151Kalnina A.; Bizdēna Ē.; Kiseļovs G.; *Mishnev A.; Turks M. Structural proof of tetrazolo[1,5-a]quinazoline Derivatives and their application in the synthesis of 4-Amino-2-(1,2,3-triazol-1-yl)quinazolines. Chem. Heterocycl. Compd. 2014, 49(11), 1667-1673.      

152*Nikitjuka A.; Jirgensons A. Synthesis, chemical and biological properties of aziridine-1-carbaldehyde oximes (Minireview). Chem. Heterocycl. Compd. 2014, 49(11), 1544-1559.      

153*Boulkroune M.; Ignatovich L.; Muravenko V.; Spura J.; Chibani A.; Jouikov V. Correlation of the homo-lumo gap in furyl and thienyl nitrones and nitroethenes with their electrochemical redox potentials. Chem. Heterocycl. Compd. 2014, 49(11), 1579-1588.      

154*Turovska B.; Goba I.; Lielpētere A.; Turovskis I.; Lūsis V.; Muceniece D.; Stradiņš J. Electron transfer reactions in the chemistry of Di- and tetrahydropyridines. Chem. Heterocycl. Compd. 2014, 49(11), 1640-1652.      

155*Zvejniece L.; Vāvers E.; Švalbe B.; Vilšķērsts R.; Domracheva I.; Vorona M.; Veinberg G.; Misane I.; Stonans I.; Kalvinsh I.; Dambrova M. The cognition-enhancing activity of E1R, a novel positive allosteric modulator of sigma-1 receptors. Br. J. Pharmacol. 2014, 171(3), 761-771.      

156*Petrova M.; Muhamadejev R.; Chesnokov A.; Vigante B.; Čekavičus B.; Plotniece A.; Duburs G.; Liepinsh E. Spectral and quantum-chemical study of nonequivalence of methylene protons in 1,4-dihydropyridine derivatives. Chem. Heterocycl. Compd. 2014, 49(11), 1631-1639.      

157Borovika D.; Bertrand P.; *Trapencieris P. Synthesis of macromonocyclic hydroxamic acids (Review). Chem. Heterocycl. Compd. 2014, 49(11), 1560-1578.      

158*Bisenieks E.; Uldriķis J.; Poikans J.; Baumane L.; Petrova M.; Liepinsh E.; Duburs G. Reactions of 9-Aroyl-3,3,6,6-Tetramethyl-1,2,3,4,5,6,7,8-Octahydroxanthene- 1,8-Diones with hydrazine and methylhydrazine. Chem. Heterocycl. Compd. 2014, 49(11), 1653-1657.      

159*Baumane L.; Krauze A.; Krasnova L.; Belyakov S.; Duburs G.; Stradiņš J. Role of steric factors in intramolecular h-bond formation and peculiarities of electrochemical oxidation of Ethyl 6-Alkylsulfanyl-5-Cyano-2-Methyl-4- Phenyl-1,4-Dihydropyridine-3-Carboxylates. Chem. Heterocycl. Compd. 2014, 49(11), 1623-1630.      

160*Arsenyan P.; Vasiļjeva J.; Shestakova I.; Domracheva I.; Belyakov S. The synthesis and cytotoxic properties of selenopheno[3,2-c]- and selenopheno-[2,3-c]quinolones. Chem. Heterocycl. Compd. 2014, 49(11), 1674-1680.      

161Aleksis R.; Jaudzems K.; Ivanova J.; Žalubovskis R.; Kalvinsh I.; *Liepinsh E. Reactivity of aziridine-2-carboxamide (leakadine) with nucleophiles in aqueous solutions. Chem. Heterocycl. Compd. 2014, 49(11), 1589-1598.      

162*Rozhenko A.B.; Mykhaylychenko S.S.; Pikun N.V.; Shermolovich Y.G.; Leszczynski J. Intermediate carbene formation in the reaction of thioamides with phosphorus (III) derivatives: Quantum chemical investigation. Int J Quantum Chem 2014, 114(4), 241-248.      

163*Krukle-Berzina K.; Actins A. Powder x-ray diffraction investigation of xylazine hydrochloride solid phase transformation kinetics. Int J Chem Kinet 2014, 46(3), 161-168.      

164Kher S.; *Jirgensons A. Synthesis of β-amino-α-ketoamides. Curr. Org. Chem. 2014, 18(17), 2240-2269.      

165Grandāne A.; Tanc M.; *Žalubovskis R.; Supuran C.T. 6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII. Bioorg. Med. Chem. Lett. 2014, 24(5), 1256-1260.      

166Grandāne A.; Tanc M.; *Žalubovskis R.; Supuran C.T. Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII. Bioorg. Med. Chem. 2014, 22(5), 1522-1528.      

167*Tars K.; Leitans J.; Kazaks A.; Zeļencova D.; Liepinsh E.; Kūka J.; Makrecka M.; Loļa D.; Andrianovs V.; Gustiņa D.; Grinberga S.; Liepinsh E.; Kalvinsh I.; Dambrova M.; Loža E.; Pugovičs O. Targeting carnitine biosynthesis: Discovery of new inhibitors against γ-butyrobetaine hydroxylase. J. Med. Chem. 2014, 57(6), 2213-2236.      

168*Pudzs K.; Vembris A.; Muzikante I.; Grzibovskis R.; Turovska B.; Simokaitiene J.; Grigalevicius S.; Grazulevicius J.V. Energy structure and electro-optical properties of organic layers with carbazole derivative. Thin Solid Films 2014, 556, 405-409.      

169*Skrastiņa I.; Baran A.; Muceniece D.; Popelis J. Synthesis of 2,5-dihydroisothiazole derivatives. 2*. 3-aryl(hetaryl)-substituted 2-alkyl-5-arylimino-2,5-dihydroisothiazoles. Chem. Heterocycl. Compd. 2014, 50(1), 87-102.      

170*Arsenyan P. A simple method for the preparation of selenopheno[3,2-b] and [2,3-b]thiophenes. Tetrahedron Lett. 2014, 55(15), 2527-2529.      

171Jaudzems K.; Tars K.; Maurops G.; Ivdra N.; Otikovs M.; Leitans J.; Kanepe-Lapsa I.; Domračeva I.; Mutule I.; Trapencieris P.; Blackman M.J.; *Jirgensons A. Plasmepsin inhibitory activity and structure-guided optimization of a potent hydroxyethylamine-based antimalarial hit. ACS Med. Chem. Lett. 2014, 5(4), 373-377.      

172Priede M.; Kazak M.; Kalniņš T.; Shubin K.; *Suna E. Diastereoselective hydroxymethylation of cyclic N-tert- butanesulfinylketimines using methoxymethanol as formaldehyde source. J. Org. Chem. 2014, 79(8), 3715-3724.      

173Gataeva O.K.; *Abaev V.T.; Kolodina A.A.; Butin A.V. Simple method for the synthesis of aryl(furfuryl)glyoxals. Chem. Heterocycl. Compd. 2014, 50(2), 296-299.      

174Grigorjeva L.; Liepinsh E.; Razafimahefa S.; Yahorau A.; Yahorava S.; Rasoanaivo P.; *Jirgensons A.; Wikberg J.E.S. Semisynthesis of libiguin A and its analogues by trans-lactonization of phragmalin. J. Org. Chem. 2014, 79(9), 4148-4153.      

175Sokolovs I.; Lubriks D.; *Suna E. Copper-catalyzed intermolecular C-H amination of (Hetero)arenes via transient unsymmetrical λ3-iodanes. J. Am. Chem. Soc. 2014, 136(19), 6920-6928.      

176Maļeckis A.; *Sanford M.S. Catalytic cycle for palladium-catalyzed decarbonylative trifluoromethylation using trifluoroacetic esters as the CF3 source. Organometallics 2014, 33(10), 2653-2660.      

177*Turks M.; Veze K.; Kiseļovs G.; Mackevica J.; Luginina J.; Mishnev A.; Markovic D. Synthesis and X-ray studies of novel 3-C-nitromethyl-hexofuranoses. Carbohydr. Res. 2014, 391(1), 82-88.      

178*Priede E.; Nakurte I.; Zicmanis A. Structure effect of imidazolium-based dicationic ionic liquids on claisen rearrangement. Synth. Commun. 2014, 44(12), 1803-1809.      

179*Zajakina A.; Vasilevska J.; Zhulenkovs D.; Skrastina D.; Spaks A.; Plotniece A.; Kozlovska T. High efficiency of alphaviral gene transfer in combination with 5-fluorouracil in a mouse mammary tumor model. BMC Cancer 2014, 14(1).      

180*Li R.I.; Butin A.V.; Ivanov S.P.; Mashin D.V. A promising polymer composite material for increasing the efficiency of recovery of basic parts of automotive engineering. Polym. Sci. - Ser. D 2014, 7(3), 233-237.      

181*Li R.I.; Butin A.V.; Kuznetsov M.M. A mathematical model of the stress state of a shaft-bearing adhesive bond under radial loading. Polym. Sci. - Ser. D 2014, 7(3), 208-212.      

182*Makarova E.; Gornas P.; Konrāde I.; Tirzīte D.; Cīrule H.; Gulbe A.; Pugajeva I.; Seglina D.; Dambrova M. Acute anti-hyperglycaemic effects of an unripe apple preparation containing phlorizin in healthy volunteers: A preliminary study. J. Sci. Food Agric. 2014, 95(3), 560-568.      

183Bobiļeva O.; Bokaldere R.; Gailite V.; Kaula I.; Ikaunieks M.; Duburs G.; Petrovska R.; Mandrika I.; Klovins J.; *Loža E. Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists. Bioorg. Med. Chem. 2014, 22(14), 3654-3669.      

184*Krukle-Berzina K.; Actins A. Investigation of the phase transitions occurring during and after the dehydration of xylazine hydrochloride monohydrate. Int. J. Pharm. 2014, 469(1), 40-49.      

185Maļeckis A.; *Sanford M.S. Synthesis of fluoroalkyl palladium and nickel complexes via decarbonylation of acylmetal species. Organometallics 2014, 33(14), 3831-3839.      

186Andersson M.; Chen G.; Otikovs M.; Landreh M.; Nordling K.; Kronqvist N.; Westermark P.; Jornvall H.; Knight S.; Ridderstrale Y.; Holm L.; Meng Q.; Jaudzems K.; Chesler M.; *Johansson J.; Rising A. Carbonic Anhydrase Generates CO2 and H+ That Drive Spider Silk Formation Via Opposite Effects on the Terminal Domains. PloS Biol. 2014, 12(8).      

187Kufareva I.; Katritch V.; Biggin P.; Kim M.; Park K.; Jung S.W.; Cho A.E.; Sands Z.A.; Ostopovici-Halip L.; Bologa C.G.; Norn C.; Brylinski M.; Skolnick J.; Keranen H.; Lenselink B.E.; Van Westen G.; Overington J.P.; De Teraan H.G.; Isberg V.; Fidom K.M.; Lehto T.M.; Gloriam D.E.; Ghosh A.; Sonavane U.; Joshi R.; Xia J.; Hsieh J.-H.; Zhang L.; Wang X.S.; Vogel H.; Yuan S.; Feng X.; Chen M.; Ambia J.; Barth P.; Gageat C.; Stepniewski M.; Xhaard H.; Kelm S.; Pitt W.R.; Shi J.; Larsen A.; Li H.; Wagner J.; Bhattacharya S.; Vaidehi N.; Kanou K.; Cvicek V.; Kim S.-K.; Trzaskowski B.; Goddard W.A.; Abrol R.; Selvam B.; Tikhonova I.G.; Cuzzolin A.; Sabbadin D.; Ciancetta A.; Moro S.; Freyd T.; Gabrielsen M.; Kristiansen K.; Sylte I.; Gaffney K.J.; Petasis N.A.; Latek D.; Bajda M.; Mlynarczyk K.; Filipek S.; Lopez L.; Kuiper M.; Beuming T.; Perez-Aguilar J.M.; Wang R.Y.-R.; Park H.; Greisen P.; Song Y.; DiMaio F.; Baker D.; Shin W.-H.; Heo L.; Lee G.R.; Seok C.; Yang J.; Zhang Y.; Ponassi M.; Rosano C.; Cheremovskiy G.; Grudinin S.; Chaudhari R.; Heim A.J.; Li Z.; Lv Q.; Grigorov M.G.; Hu X.; Sun H.; Shen M.; Southall N.; Jadhav A.; Rodriguez D.; Ranganathan A.; Carlsson J.; Najmanovich R.; Durdagi S.; De March C.; Diharce J.; Golebiowski J.; Antonczak S.; Fiorucci S.; Nguyen E.; Meiler J.; Gutcaits A.; Marti-Solano M.; Pastor M.; Selent J.; *Stevens R.C.; Abagyan R. Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: Meeting new challenges. Structure 2014, 22(8), 1120-1139.      

188Čekavičus B.; Vigante B.; Ruciņš M.; Plotniece A.; Pajuste K.; Petrova M.; Belyakov S.; Duburs G.; *Sobolev A. Cyclisation of benzo[b]thiophen-3(2H)-one 1,1-dioxide and 1,3-indanedione into novel methylene bridged polycyclic diazocines and their rearrangement into spirocyclic compounds. Tetrahedron Lett. 2014, 55(33), 4601-4604.      

189*Abaev V.T.; Plieva A.T.; Chalikidi P.N.; Uchuskin M.G.; Trushkov I.V.; Butin A.V. A simple route to polysubstituted indoles exploiting azide induced furan ring opening. Org. Lett. 2014, 16(16), 4150-4153.      

190Kurudenkandy F.R.; Zilberter M.; Biverstal H.; Presto J.; Honcharenko D.; Stromberg R.; Johansson J.; Winblad B.; *Fisahn A. Amyloid-β-induced action potential desynchronization and degradation of hippocampal gamma oscillations is prevented by interference with peptide conformation change and aggregation. J. Neurosci. 2014, 34(34), 11416-11425.      

191Uchuskin M.G.; Makarov A.S.; *Butin A.V. Catalytic alkylation of furans by π-activated alcohols (review). Chem. Heterocycl. Compd. 2014, 50(6), 791-806.      

192Barbet-Massin E.; Pell A.J.; Retel J.S.; Andreas L.B.; Jaudzems K.; Franks W.T.; Nieuwkoop A.J.; Hiller M.; Higman V.; Guerry P.; Bertarello A.; Knight M.J.; Felletti M.; Le Marchand T.; Kotelovica S.; Akopjana I.; Tars K.; Stoppini M.; Bellotti V.; Bolognesi M.; Ricagno S.; Chou J.J.; Griffin R.G.; Oschkinat H.; Lesage A.; Emsley L.; Herrmann T.; *Pintacuda G. Rapid proton-detected NMR assignment for proteins with fast magic angle spinning. J. Am. Chem. Soc. 2014, 136(35), 12489-12497.      

193Grigorjeva L.; *Daugulis O. Cobalt-catalyzed direct carbonylation of aminoquinoline benzamides. Org. Lett. 2014, 16(17), 4688-4690.      

194Grigorjeva L.; *Daugulis O. Cobalt-catalyzed, aminoquinoline-directed coupling of sp2 C-H bonds with alkenes. Org. Lett. 2014, 16(17), 4684-4687.      

195Buraka E.; Chen C.Y.-C.; Gavare M.; Grube M.; Makarenkova G.; Nikolajeva V.; Bisenieks I.; Bruvere I.; Bisenieks E.; Duburs G.; *Sjakste N. DNA-binding studies of AV-153, an antimutagenic and DNA repair-stimulating derivative of 1,4-dihydropiridine. Chem.-Biol. Interact. 2014, 220, 200-207.      

196*Honcharenko D.; Bose P.P.; Maity J.; Kurudenkandy F.R.; Juneja A.; Floistrup E.; Biverstal H.; Johansson J.; Nilsson L.; Fisahn A.; Stromberg R. Synthesis and evaluation of antineurotoxicity properties of an amyloid-β peptide targeting ligand containing a triamino acid. Org. Biomol. Chem. 2014, 12(34), 6684-6693.      

197Grigorjeva L.; *Daugulis O. Cobalt-catalyzed, aminoquinoline-directed C(sp2)-H bond alkenylation by alkynes. Angew. Chem. Int. Ed. 2014, 53(38), 10209-10212.      

198Kher S.S.; Penzo M.; Fulle S.; Finn P.W.; Blackman M.J.; *Jirgensons A. Substrate derived peptidic α-ketoamides as inhibitors of the malarial protease PfSUB1. Bioorg. Med. Chem. Lett. 2014, 24(18), 4486-4489.      

199Shiroodi R.K.; Koleda O.; *Gevorgyan V. 1,2-boryl migration empowers regiodivergent synthesis of borylated furans. J. Am. Chem. Soc. 2014, 136(38), 13146-13149.      

200*Goba I.; Turovska B.; Belyakov S.; Liepinsh E. Synthesis, spectroscopic and conformational analysis of 1,4-dihydroisonicotinic acid derivatives. J. Mol. Struct. 2014, 1074, 549-558.      

201*Ignatovich L.; Romanovs V.; Muravenko V.; Sleiksha I.; Popelis J.; Shestakova I. Synthesis and cytotoxic activity of 1-{3-[1-(5-organylsilylfuran-2-Yl)silinan-1-Yl]propyl}amines and some trimethylgermyl analogues. Chem. Eur. J. 2014, 20(40), 12786-12788.      

202*Sjakste T.; Paramonova N.; Rumba-Rozenfelde I.; Trapiņa I.; Sugoka O.; Sjakste N. Juvenile idiopathic arthritis subtype- and sex-specific associations with genetic variants in the PSMA6/PSMC6/PSMA3 gene cluster. Pediatr. Neonatol. 2014, 55(5), 393-403.      

203*Priede E.; Bakis E.; Zicmanis A. When Chlorides are the Most Reactive: A Simple Route towards Diverse Mono- and Dicationic Dimethyl Phosphate Ionic Liquids. Synlett 2014, 25(17), 2447-2450.      

204Stan-Sion C.; Enachescu M.; Petre A.R.; Duma M.; Ghita D.G.; Kizane G.; Baumane L.; Gabrusenoks J.; Halitovs M.; Avotina L.; Zarins A.; *Likonen J.; Koivuranta S.; Kiisk M. Comparison of tritium measurement techniques for a laser cleaned JET tile. Fusion Eng Des 2014, 89(11), 2628-2634.      

205Veliks J.; Tseng J.-C.; Arias K.I.; Weisshar F.; Linden A.; *Siegel J.S. Linear bilateral extended 2,2′:6′,2′′-terpyridine ligands, their coordination complexes and heterometallic supramolecular networks. Chem. Sci. 2014, 5(11), 4317-4327.      

206*Zhulenkovs D.; Rudevica Z.; Jaudzems K.; Turks M.; Leonchiks A. Discovery and structure-activity relationship studies of irreversible benzisothiazolinone-based inhibitors against Staphylococcus aureus sortase A transpeptidase. Bioorg. Med. Chem. 2014, 22(21), 5988-6003.      

207*Krauze A.; Grīnberga S.; Krasnova L.; Adlere I.; Sokolova E.; Domracheva I.; Shestakova I.; Andžāns Z.; Duburs G. Thieno[2,3-b]pyridines - A new class of multidrug resistance (MDR) modulators. Bioorg. Med. Chem. 2014, 22(21), 5860-5870.      

208*Kūka J.; Liepinsh E.; Makrecka-Kuka M.; Liepins J.; Cīrule H.; Gustiņa D.; Loža E.; Zharkova-Malkova O.; Grinberga S.; Pugovičs O.; Dambrova M. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation. LIFE SCI. 2014, 117(2), 84-92.      

209Nikitjuka A.; Nekrasova A.; *Jirgensons A. Methylprenyl and prenyl protection for sulfonamides. Synlett 2014, 25(9).      

210Veliks J.; Blacque O.; *Siegel J.S. Three steps in one pot: Synthesis of linear bilateral extended 2,2′:6′,2-terpyridineruthenium(II) complexes. Inorg. Chem. 2014, 53(22), 12122-12126.      

211Ahlin J.S.E.; Donets P.A.; Cramer N. Nickel(0)-catalyzed enantioselective annulations of alkynes and arylenoates enabled by a chiral NHC ligand: Efficient access to cyclopentenones. Angew. Chem. Int. Ed. 2014, 53(48), 13229-13233.      

212*Arsenyan P.; Paegle E.; Domracheva I.; Gulbe A.; Kanepe-Lapsa I.; Shestakova I. Selenium analogues of raloxifene as promising antiproliferative agents in treatment of breast cancer. Eur. J. Med. Chem. 2014, 87, 471-483.      

213*Butin A.V.; Trushkov I.V.; Serdyuk O.V.; Abaev V.T. Fluorinated furans and benzofurans. Fluor. in Heterocycl. Chem. 2014, 1, 181-231.      

214*Serdyuk O.V.; Abaev V.T.; Butin A.V.; Nenajdenko V.G. Fluorinated thiophenes and their analogues. Fluor. in Heterocycl. Chem. 2014, 1, 233-277.      

215*Romanchikova N.; Trapencieris P.; Zemitis J.; Turks M. A novel matrix metalloproteinase-2 inhibitor triazolylmethyl aziridine reduces melanoma cell invasion, angiogenesis and targets ERK1/2 phosphorylation. J. Enzyme Inhib. Med. Chem. 2014, 29(6), 765-772.      

216*Bobrovs R.; Seton L.; Actins A. Solvent-mediated phase transformation between two tegafur polymorphs in several solvents. Crystengcomm 2014, 16(46), 10581-10591.      

Patenti un patentu pieteikumi
217Kalvins Ivars; Dambrova Maija; Liepins Edgars; Pugovics Osvalds; Vilskersts Reinis; Kuka Janis; Grinberga Solveiga; Loza Einars. Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease. KR101355417, 27.01.2014.      

218Kalvins Ivars; Dambrova Maija; Liepins Edgars; Stonans Ilmars. 4-[(Haloalkyl)dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular.... CN103547562, 29.01.2014.      

219Stonans Ilmars; Dambrova Maija; Liepins Edgars; Kalvins Ivars; Loza Einars; Lola Daina; Kuka Janis; Pugovics Osvalds; Vilskersts Reinis; Grinberga Solveiga. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular .... CU20130146, 29.01.2014.      

220Cernobrovijs Aleksandrs; Ievina Agnija; Kalvins Ivars; Lebedevs Antons; Veinbergs Grigorijs; Vorona Maksims. Regeneration of 2,2'-cyclopropylidene-bis(oxazolines). EA019170, 30.01.2014.      

221Pfau Roland; Arndt Kirsten; Doods Henri; Klinder Klaus; Kuelzer Raimund; Lubriks Dmitrijs; Mack Juergen; Pelcman Benjamin; Priepke Henning; Roenn Robert; Stenkamp Dirk; Suna Edgars. 3H-imidazo[4,5-c]pyridine-6-carboxamides as anti inflammatory agents. NZ594589, 31.01.2014.      

222William Finn Paul; Loza Einars; Duffy James; Watkins Clare; Dikovska Klara; Kalvins Ivars; Harris C John; Ritchie James; Gailite Vija; Vorona Maksims; Piskunova Irene; Rosario Romero Martin Maria; Starchenkov Igors. Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors. DK1328510, 03.02.2014.      

223Stonans Ilmars; Veinbergs Grigorijs; Cernobrovijs Aleksandrs; Dambrova Maija; Kalvins Ivars; Zvejniece Liga; Vorona Maksims. 4R,5R-Enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity. EP2694474, 12.02.2014.      

224Voznijs Igors; Borovika Diana; Kalvins Ivars; Zalubovskis Raivis; Pelss Janis. 8-hinolin- un 8-piridin-2,6-diazabiciklo[2.2.2.]oktan-3,5-dioni ka potencialie pretveza un pretiekai. LV14710, 20.02.2014.      

225Kalvins Ivars; Arsenjans Pavels; Shestakova Irina; Domracheva Ilona. Amonija seleniti un teluriti ka glutationa peroksidazes inhibesanas lidzekli. LV14709, 20.02.2014.      

226Kalvins Ivars; Dambrova Maija; Liepins Edgars; Stonans Ilmars. 4-[(Haloalkyl)dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular.... EA201301079, 28.02.2014.      

227William Finn Paul; Loza Einars; Duffy James; Watkins Clare; Dikovska Klara; Kalvins Ivars; Harris C John; Ritchie James; Gailite Vija; Vorona Maksims; Piskunova Irene; Rosario Romero Martin Maria; Starchenkov Igors. Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors. ES2445578, 04.03.2014.      

228Kalvins Ivars; Dambrova Maija; Liepins Edgars; Stonans Ilmars. 4-[(Haloalkyl)dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular.... EP2702037, 05.03.2014.      

229Kalvins Ivars; Stonans Ilmars; Dambrova Maija; Liepins Edgars; Grinberga Solveiga; Kuka Janis; Lola Daina; Loza Einars; Pugovics Osvalds; Vilskersts Reinis. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular .... EP2702033, 05.03.2014.      

230Pfau Roland; Arndt Kirsten; Doods Henri; Klinder Klaus; Kuelzer Raimund; Lubriks Dmitrijs; Mack Juergen; Pelcman Benjamin; Priepke Henning; Roenn Robert; Stenkamp Dirk; Suna Edgars. 3H-imidazo[4,5-c]pyridine-6-carboxamides as anti inflammatory agents. JP5433708, 05.03.2014.      

231Kalvins Ivars; Stonans Ilmars; Dambrova Maija; Svalbe Baiba; Cirule Helena; Vilskersts Reinis; Jonane-Osa Indra. Use of 3-(2,2,2-trimethylhydrazinium)-ethylpropionate or a pharmaceutically acceptable salt for .... WO2014032735, 06.03.2014.      

232Martinus Boeren Marinus Maria; Johannes Paridaans Rudolf; Petkune Sanita; Lusis Viesturs; Muceniece Dzintra; Animal Health B V Eurovet. Crystalline pimobendan, process fo the preparation thereof, pharmaceutical composition and use. US8680101, 25.03.2014.      

233Reine Inese; Zandersons Armands. Method for preparing medetomidine and its salts. CA2660365, 25.03.2014.      

234Kalvins Ivars; Birmans Anatolijs; Veveris Maris; Lebedevs Antons; Misnovs Anatolijs. Novel acetylsalicyclic acid salts. EP2445861, 26.03.2014.      

235Kalvins Ivars; Stonans Ilmars; Dambrova Maija; Liepins Edgars; Grinberga Solveiga; Kuka Janis; Lola Daina; Loza Einars; Pugovics Osvalds; Vilskersts Reinis. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular .... US2014088125, 27.03.2014.      

236Kalvins Ivars; Stonans Ilmars; Shestakova Irina. Pharm.combin. of 1-(2-tetrahydrofuryl)-5-fluorouracil and caffeic acid phenethyl ester for oral .... EA19408, 31.03.2014.      

237Kauss Valerjans; Jirgensons Aigars; Gold Markus. Method of preparing Neramexane or a salt thereof. US8692021, 08.04.2014.      

238Kalvins Ivars; Lebedevs Antons; Cernobrovijs Aleksandrs; Dambrova Maija; Zvejniece Liga; Vorona Maksims; Veinbergs Grigorijs. 4R,5S-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity. CA2780040, 08.04.2014.      

239Kalvins Ivars; Lebedevs Antons; Cernobrovijs Aleksandrs; Dambrova Maija; Zvejniece Liga; Vorona Maksims; Veinbergs Grigorijs. 4R,5S-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity. RS53014, 30.04.2014.      

240Kalvins Ivars; Dambrova Maija; Liepins Edgars; Makarova Elina; Pugovics Osvalds; Grinberga Solveiga; Sevostjanovs Eduards; - WIPO OMPI. Pharmaceutical composition for reducing trimethylamine N-oxide level. WO2014064630, 01.05.2014.      

241Erchak Nikolai; Kalvins Ivars; Belyakov Sergey; Malgorzata Zielonka; Liepins Edvards; Arsenjans Pavels; Olszewska Ewa. Method for preparing N-morpholiniomethylspirobi(2,5-dioxa-3-oxo-1-silacyclopentan)ate. LV14733, 20.05.2014.      

242Liepins Edvards; Arsenjans Pavels; Olszewska Ewa; Erchak Nikolai; Kalvins Ivars; Belyakov Sergey; Malgorzata Zielonka. Method for preparing N-morpholinomethylosilan. LV14734, 20.05.2014.      

243Ozola Vita; Suna Edgars; Scott L Dax; Mannion James; Golder Francis John; Macintyre Duncan Euan; McLeod James; Shubin Kirill; Mencel James Joseph; Peng Sean. Novel orally bioavailable breathing control modulating compounds, and methods of using same. CA2891342, 22.05.2014.      

244Ozola Vita; Suna Edgars; Scott L Dax; Mannion James; Golder Francis John; Macintyre Duncan Euan; McLeod James; Shubin Kirill; Mencel James Joseph; Peng Sean. Novel orally bioavailable breathing control modulating compounds, and methods of using same. WO2014078575, 22.05.2014.      

245Kalvins Ivars; Birmans Anatolijs; Veveris Maris; Lebedevs Antons; Misnovs Anatolijs. A novel therapeutically combination of nicotinic acid and meldonium. CN102802618, 18.06.2014.      

246Pugovics Osvalds; Dambrova Maija; Kuka Janis; Liepins Edgars; Loza Einars; Stonans Ilmars; Kalvins Ivars; Vilskersts Reinis; Andrianov Victor; Grinberga Solveiga; Gustina Daina; Lola Daina; Makrecka-Kuka Marina. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium or a pharmaceutically acceptable salt.... CA2895574, 26.06.2014.      

247Pugovics Osvalds; Dambrova Maija; Kuka Janis; Liepins Edgars; Loza Einars; Stonans Ilmars; Kalvins Ivars; Vilskersts Reinis; Andrianov Victor; Grinberga Solveiga; Gustina Daina; Lola Daina; Makrecka-Kuka Marina. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium or a pharmaceutically acceptable salt.... WO2014096133, 26.06.2014.      

248Kalvins Ivars; Dambrova Maija; Liepins Edgars; Pugovics Osvalds; Vilskersts Reinis; Kuka Janis; Grinberga Solveiga; Loza Einars. Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease. CN102666476, 09.07.2014.      

249Kalvins Ivars; Dambrova Maija; Liepins Edgars; Pugovics Osvalds; Vilskersts Reinis; Kuka Janis; Grinberga Solveiga; Loza Einars. Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease. JP5552169, 16.07.2014.      

250Stonans Ilmars; Dambrova Maija; Liepins Edgars; Grinberga Solveiga; Kuka Janis; Lola Daina; Loza Einars; Pugovics Osvalds; Vilskersts Reinis; Kalvins Ivars. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular .... PE07772014, 20.07.2014.      

251Priepke Henning; Doods Henri; Kuelzer Raimund; Pfau Roland; Stenkamp Dirk; Pelcman Benjamin; Roenn Robert; Lubriks Dmitrijs; Suna Edgars. 2-(Arylamino)-3H-imidazo[4,5-b]pyridine-6-carboxamide derivatives and their use as MPGES-1 .... JP5554450, 23.07.2014.      

252Kalvins Ivars; Dambrova Maija; Liepins Edgars; Pugovics Osvalds; Vilskersts Reinis; Kuka Janis; Grinberga Solveiga; Loza Einars. Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease. EP2491005, 23.07.2014.      

253Wikberg Jarl; Jirgensons Aigars; Liepins Edvards. Phragmalin limonoids for the treatment of sexual dysfunction. AU2013213580, 24.07.2014.      

254Kalvins Ivars; Lebedevs Antons; Cernobrovijs Aleksandrs; Dambrova Maija; Zvejniece Liga; Vorona Maksims; Veinbergs Grigorijs. 4R,5S-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity. US8791273, 29.07.2014.      

255Stonans Ilmars; Dambrova Maija; Liepins Edgars; Grinberga Solveiga; Kuka Janis; Lola Daina; Loza Einars; Pugovics Osvalds; Vilskersts Reinis; Kalvins Ivars. Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium salts in the treatment of cardiovascular .... ZA201307614, 30.07.2014.      

256Pfau Roland; Arndt Kirsten; Doods Henri; Klinder Klaus; Kuelzer Raimund; Lubriks Dmitrijs; Mack Juergen; Pelcman Benjamin; Priepke Henning; Roenn Robert; Stenkamp Dirk; Suna Edgars. 3H-imidazo[4,5-c]pyridine-6-carboxamides as anti inflammatory agents. CN102341395, 30.07.2014.      

257Kalvins Ivars; Lebedevs Antons; Cernobrovijs Aleksandrs; Dambrova Maija; Zvejniece Liga; Vorona Maksims; Veinbergs Grigorijs. 4R,5S-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity. EA19890, 30.07.2014.      

258Ponomarjovs Jurijs; Borovika Diana; Cernobrovijs Aleksandrs; Lebedevs Antons. 2-metil-4-(4-metilpiperazin-1-il)-10H-tieno[2,3-b][1,5]benzodiazepina iegusanas panemiens. LV14853, 20.08.2014.      

259Birmans Anatolijs; Veveris Maris; Lebedevs Antons; Misnovs Anatolijs; Kalvins Ivars. Novel acetylsalicyclic acid salts. UA106379, 26.08.2014.      

260Birmans Anatolijs; Veveris Maris; Lebedevs Antons; Misnovs Anatolijs; Kalvins Ivars. Novel acetylsalicylic acid salts. HK1169648, 05.09.2014.      

261William Finn Paul; Loza Einars; Duffy James; Watkins Clare; Dikovska Klara; Harris C John; Ritchie James; Gailite Vija; Vorona Maksims; Piskunova Irene; Rosario Romero Martin Maria; Starchenkov Igors; Kalvins Ivars. Hydroxamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors. CA2765409, 16.09.2014.      

262Martjuga Marina; Scott L Dax; Ozola Vita; Suna Edgars; Mencel James Joseph; Shubin Kirill. Novel breathing control modulating compounds, and methods of using same. CA2905950, 25.09.2014.      

263Martjuga Marina; Scott L Dax; Ozola Vita; Suna Edgars; Mencel James Joseph; Shubin Kirill. Novel breathing control modulating compounds, and methods of using same. WO2014151462, 25.09.2014.      

264Liepins Edvards; Arsenjans Pavels; Olszewska Ewa; Erchak Nikolai; Kalvins Ivars; Belyakov Sergey; Malgorzata Zielonka. Method for preparing N-morpholinomethylosilan. PL217933, 30.09.2014.      

265Cernobrovijs Aleksandrs; Ievina Agnija; Kalvins Ivars; Lebedevs Antons; Veinbergs Grigorijs; Vorona Maksims. Regeneration of 2,2'-cyclopropylidene-bis(oxazolines). US8846944, 30.09.2014.      

266Kalvins Ivars; Lebedevs Antons; Cernobrovijs Aleksandrs; Dambrova Maija; Zvejniece Liga; Vorona Maksims; Veinbergs Grigorijs. 4R,5S-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity. US2014296317, 02.10.2014.      

267Duburs Gunars; Klovins Janis; Bruvere Imanta; Petrovska Ramona; Mandrika Ilona; IGNATOVICA VITA; Bisenieks Egils; Uldrikis Janis; Poikans Janis; Vigante Brigita. 1,4-dihidropiridin-4-il-piridinija atvasinajumi ka jauni adenozina A2A receptora agoallosteriskie. LV14884, 20.10.2014.      

268Pfau Roland; Arndt Kirsten; Doods Henri; Klinder Klaus; Kuelzer Raimund; Lubriks Dmitrijs; Mack Juergen; Pelcman Benjamin; Priepke Henning; Roenn Robert; Stenkamp Dirk; Suna Edgars. 3H-imidazo[4,5-c]pyridine-6-carboxamides as anti inflammatory agents. EP2403852, 29.10.2014.      

269Pfau Roland; Arndt Kirsten; Doods Henri; Klinder Klaus; Kuelzer Raimund; Lubriks Dmitrijs; Mack Juergen; Pelcman Benjamin; Priepke Henning; Roenn Robert; Stenkamp Dirk; Suna Edgars. 3H-imidazo[4,5-c]pyridine-6-carboxamides as anti inflammatory agents. EA020282, 30.10.2014.      

270Kalvins Ivars; Dambrova Maija; Liepins Edgars; Pugovics Osvalds; Vilskersts Reinis; Kuka Janis; Grinberga Solveiga; Loza Einars. Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease. EA020303, 30.10.2014.      

271Jirgensons Aigars; Leitis Gundars; Robinson Daniel; William Finn Paul; Khan Nagma; Kalvins Ivars. Bicyclosulfonyl acid (BC SA) compounds and their use as therapeutic agents. BRPI0811651, 11.11.2014.      

272Kalvins Ivars; Birmans Anatolijs; Veveris Maris; Lebedevs Antons; Misnovs Anatolijs. Novel acetylsalicyclic acid salts. US8889902, 18.11.2014.      

273Lusis Viesturs; Stupnikova Svetlana; Muceniece Dzintra; Zandersons Armands; Laipnieks Deniss; Lavrinovics Edvards; Jonane-Osa Indra. Intermediates for a novel process of preparing imatinib and related tyrosine kinase inhibitors. GB2514285, 19.11.2014.      

274Birmans Anatolijs; Veveris Maris; Lebedevs Antons; Misnovs Anatolijs; Kalvins Ivars. A novel therapeutically combination of nicotinic acid and meldonium. UA107083, 25.11.2014.      

275Kalvins Ivars; Dambrova Maija; Liepins Edgars; Stonans Ilmars. 4-[(Haloalkyl)dimethyl)ammonio]butanoates and use thereof in the treatment of cardiovascular.... ZA201307847, 26.11.2014.      

276Wikberg Jarl; Jirgensons Aigars; Liepins Edvards. Phragmalin limonoids for the treatment of sexual dysfunction. EP2807170, 03.12.2014.      

277Dambrova Maija; Liepins Edgars; Pugovics Osvalds; Vilskersts Reinis; Kuka Janis; Grinberga Solveiga; Loza Einars; Kalvins Ivars. Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease. HRP20140964, 05.12.2014.      

278Krauze Aivars; Kalvins Ivars; Grinberga Signe; Krasnova Laura; Jaschenko Elina; Domracheva Ilona; Adlere Ilze; Andzans Zigmars; Shestakova Irina; Duburs Gunars. Thieno[2,3-b]pyridines as multidrug resistance modulators. WO2014199195, 18.12.2014.      

279Kalvins Ivars; Lebedevs Antons; Cernobrovijs Aleksandrs; Dambrova Maija; Zvejniece Liga; Vorona Maksims; Veinbergs Grigorijs. 4R,5S-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity. UA107367, 25.12.2014.      

280Pfau Roland; Arndt Kirsten; Doods Henri; Klinder Klaus; Kuelzer Raimund; Lubriks Dmitrijs; Mack Juergen; Pelcman Benjamin; Priepke Henning; Roenn Robert; Stenkamp Dirk; Suna Edgars. 3H-imidazo[4,5-c]pyridine-6-carboxamides as anti inflammatory agents. US8921405, 30.12.2014.      

281Kalvins Ivars; Birmans Anatolijs; Veveris Maris. Corrector of endothelial dysfunction. WO2014209092, 31.12.2014.      

282Wikberg Jarl; Jirgensons Aigars; Liepins Edvards. Phragmalin limonoids for the treatment of sexual dysfunction. CN104254537, 31.12.2014.      

283Dambrova Maija; Liepins Edgars; Pugovics Osvalds; Vilskersts Reinis; Kuka Janis; Grinberga Solveiga; Loza Einars; Kalvins Ivars. Use of 4-[Ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease. SI2491005, 31.12.2014.      

Publicistika
284Konrāde I.; Jēkabsone A.; Kalere I.; Tetere E.; Dambrova M.; Makrecka M.; Strēle I.; Neimane L.; Lejnieks A.; Pīrāgs V.. Nodrošinājums ar jodu Latvijā – aizmirstas problēmas klīniskās konsekvences.. Latvijas Ārsts. 2014, februāris, 23-28.      

285Kalvinš I.. Reģionālās augstskolas misija un tās īstenošana.. Izglītība un Kultūra 2014, 26. februāris.      

286Dambrova M.; Makrecka M.; Kūka J.; Liepiņš E.. L-karnitīns: uztura bagātinātājs vai jauns kardiovaskulārā riska marķieris? . Latvijas Ārsts 2014, aprīlis, 76-79.      

Citas publikācijas
287Петухов В.И.; Баумане Л.Х.; Дмитриев Е.В.; Ванин А.Ф. ГИПОТЕЗА: ЧТО МОГУТ ОЗНАЧАТЬ КОЛИЧЕСТВЕННЫЕ СДВИГИ ЭЛЕКТРОГЕННЫХ МЕТАЛЛОВ В ЭПИДЕРМАЛЬНЫХ КЛЕТКАХ НА ФОНЕ ОКИСЛИТЕЛЬНОГО НИТРОЗАТИВНОГО СТРЕССА? Электронный журнал УДК 577.3 - DOI: 10.12737/4799 http://medtsu.tula.ru/VNMT/Bulletin/E2014-1/4824.pdf. Вестник новых мед.технологий (Тула, Россия) 2014(No. 1. ), 1-6.      

288Petukhov V.I.; Baumane L.H.; Dmitriev E.V.; Vanin A.F. Quantitative Shifts of Electrogenic Metals in Epidermal Cells in the Setting of Oxidative/Nitrosative Stress – What Could They Stand For? . Biotechnology & Biochemical Engeneering 2014, vol.2(No.2), 1045.      

289Щуков А.Н.; Быкова Е.А.; Петухов В.И.; Баумане Л. Железодефицитные состояния (ЖДС) как предиктор репродуктивных нарушений. . Евразийский Союз Ученых (ЕСУ) 2014(№6), 69-70.      

290Abele E. RECENT ADVANCES IN THE SYNTHESIS AND TRANSFORMATIONS OF HETEROCYCLES MEDIATED BY FLUORIDE ION ACTIVATED SILANES. Latvian J. Chem. 2014(1), 3-17.      

291Abele E.; Rubina K.; Beresneva T. Cu-​catalyzed reactions of 2-​imidazolethiones, 2-​aminbenzothiazoles and 2-​amino-​1-​benzylbenzoimidazole with o-​halogen derivatives of benzoic (or nicotinic) acid chlorides. Heterocyclic Letters 2014, 4(1), 147-152.      

292Abele E.; Abele Ramona. Cu-CATALIZED "ON-WATER" REARRANGEMENT OF 2-AMINOBENZOTHIAZOLES TO PHENOTHIAZINES, REACTIONS OF SUBSTITUTED 2-AMINOTHIAZOLES AND 2-AMINI-3-BENZYLBENZOTHIAZOL-3-IUM BROMIDE WITH 1,2-DIBROMOBENZENES ANDTETRACHLOROETHYLENE. Heterocyclic Letters 2014, 4(1), 109-113.      

293Kalviņš I. Jauni aterosklerozes attīstības patoģēnētiskie faktori - potenciālie zāļu mērķi.. Latvijas Ārsts. 2014, jūnijs/jūlijs, 112-115.